Actavis was a generics giant whose rise mirrors the huge growth of off-patent medicines, while Gilead has rocketed into pharma's top 20 biggest companies in 2014 thanks to ground and record ...

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

Consolidated, Actavis Group's business in Romania (including production, distribution, parent company product sales and exports of cancer treatment drugs) attained 122 million euros last year.

The fines were also levied because the two companies persuaded ... (now known as Advanz Pharma) and Waymade to stay out of the market, according to the authority, while Actavis UK continued ...

Companies that have grown profits and net profit margins over the past 12 months ...

This comes nine years after the company made bold moves overseas as it acquired Actavis’ UK and Actavis Ireland businesses from Teva Pharmaceutical Industries Ltd for around $769 million. VCCircle ...

Earlier in his career, he held positions at pharmaceutical companies including Actavis PLC (now AbbVie, Inc. (ABBV)), the US subsidiary of Swiss company Nycomed Pharma S.A., which has since been ...

The total market size of the Indian Pharma Industry is expected to reach US$ 130 billion by 2030 and US$ 450 billion market by 2047. * Indian pharmaceutical companies are projected to achieve a ...

Cosmo Pharmaceuticals SA operates as a pharmaceutical company that engages in the manufacturing of pharmaceutical drugs. It focuses on the development of gastro-intestinal pharmaceutical products ...

Yet, the cost of those innovations places new drugs out of reach for many patients and significantly burdens others. Are pharmaceutical companies earning too much? Deciding whether pharmaceutical ...